NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 10481-0112-08 — Ferric subsulfate topical solution, 8 mL bottleAI (357 hospitals, 30,291–31,155 samples)
• NDC 17478-0235-35 — Neomycin, bacitracin and polymyxin B eye ointmentAI (151 hospitals, 30,291–31,155 samples)
• NDC 50383-0267-30 — CLOBETASOL 0.05 % TOPICAL CREAMAI (88 hospitals, 30,291–31,155 samples)
• NDC 57896-0147-01 — DICLOFENAC 1 % TOPICAL GELAI (120 hospitals, 30,291–31,155 samples)
• NDC 70677-0143-01 — DICLOFENAC 1 % TOPICAL GELAI (59 hospitals, 30,291–31,155 samples)
• NDC 72266-0196-01 — Tobramycin eye dropsAI (66 hospitals, 30,291–31,155 samples)
• NDC 00409-2308-21 — Midazolam injection, 5 mg/mLAI (374 hospitals, 28,770–31,155 samples)
• NDC 17478-0715-10 — BRIMONIDINE 0.2 % EYE DROPSAI (230 hospitals, 30,291–31,155 samples)
• NDC 76282-0103-39 — DICLOFENAC 1 % TOPICAL GELAI (82 hospitals, 30,291–31,155 samples)
• NDC 00121-0577-16 — Lactulose 10 g/15 mL oral solutionAI (85 hospitals, 30,291–31,155 samples)
• NDC 50383-0779-16 — Lactulose 10 g/15 mL oral solutionAI (118 hospitals, 30,291–31,155 samples)
• NDC 60432-0037-32 — Lactulose oral solutionAI (73 hospitals, 30,291–31,155 samples)
• NDC 62332-0501-05 — OLOPATADINE 0.1 % EYE DROPSAI (31 hospitals, 30,291–31,155 samples)
• NDC 62559-0111-11 — Hydrocortisone 100 mg rectal enemaAI (174 hospitals, 30,291–31,155 samples)
• NDC 65219-0389-10 — Electrolyte-A intravenous fluid solutionAI (71 hospitals, 30,291–31,155 samples)
• NDC 72603-0192-01 — OFLOXACIN 0.3 % EYE DROPSAI (116 hospitals, 30,291–31,155 samples)
• NDC 72603-0203-25 — Ephedrine sulfate 50 mg/mL injection, intravenousAI (75 hospitals, 30,291–31,155 samples)
• NDC 00781-7515-14 — Budesonide 0.25 mg/2 mL nebulizer suspensionAI (57 hospitals, 30,291–31,155 samples)
• NDC 43598-0765-07 — OLOPATADINE 0.1 % EYE DROPSAI (81 hospitals, 30,291–31,155 samples)
• NDC 54643-7862-08 — Adult multivitamin infusion with vitamin K, vial 1 of 2AI (52 hospitals, 30,291–31,155 samples)
• NDC 65219-0389-02 — ELECTROLYTE-A INTRAVENOUS SOLUTIONAI (65 hospitals, 30,291–31,155 samples)
• NDC 00990-7670-03 — Electrolyte intravenous solutionAI (87 hospitals, 30,291–31,155 samples)
• NDC 72485-0509-01 — Etomidate injection, intravenousAI (86 hospitals, 30,291–31,155 samples)
• NDC 54643-7862-09 — Multivitamin with vitamin K IV solutionAI (40 hospitals, 30,291–31,155 samples)
• NDC 38779-0068-08 — Citric acid powder, bulkAI (33 hospitals, 30,291–31,155 samples)
• NDC 66794-0255-02 — Zinc sulfate intravenous solutionAI (48 hospitals, 30,291–31,155 samples)
• NDC 76282-0641-37 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (43 hospitals, 30,291–31,155 samples)
• NDC 72603-0209-25 — Sodium bicarbonate 8.4% intravenous solutionAI (69 hospitals, 30,291–31,155 samples)
• NDC 38779-0068-09 — Citric acid powder (bulk)AI (26 hospitals, 30,291–31,155 samples)
• NDC 56331-0006-16 — norflurane-pentafluoropropane topical sprayAI (57 hospitals, 30,291–31,155 samples)
• NDC 52565-0014-26 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENTAI (53 hospitals, 30,291–31,155 samples)
• NDC 60432-0037-08 — Lactulose oral solutionAI (56 hospitals, 30,291–31,155 samples)
• NDC 17478-0519-19 — MOXIFLOXACIN 0.5 % EYE DROPSAI (58 hospitals, 30,291–31,155 samples)
• NDC 70677-1156-01 — OLOPATADINE 0.1 % EYE DROPSAI (35 hospitals, 30,291–31,155 samples)
• NDC 47781-0305-11 — Rivastigmine 9.5 mg/24-hour skin patchAI (86 hospitals, 30,291–31,155 samples)
• NDC 50383-0363-15 — Lidocaine viscous 2% oral solutionAI (165 hospitals, 30,291–31,155 samples)
• NDC 47781-0617-22 — Rocuronium injection, 10 mg per mLAI (44 hospitals, 30,291–31,155 samples)
• NDC 72603-0164-01 — DESONIDE 0.05 % TOPICAL OINTMENTAI (51 hospitals, 30,291–31,155 samples)
• NDC 00990-7965-09 — Electrolyte solution in 5% dextrose, IVAI (28 hospitals, 30,291–31,155 samples)
• NDC 63629-2095-01 — Lidocaine 2% mucosal solutionAI (41 hospitals, 30,291–31,155 samples)
• NDC 60505-0848-05 — Azelastine nasal spray bottleAI (68 hospitals, 30,291–31,155 samples)
• NDC 61141-4837-15 — Fentanyl and bupivacaine nerve block solutionAI (28 hospitals, 30,291–31,155 samples)
• NDC 16714-0095-25 — Levalbuterol 0.63 mg/3 mL nebulizer solutionAI (26 hospitals, 30,291–31,155 samples)
• NDC 72603-0620-04 — Formoterol fumarate 20 mcg nebulizer solutionAI (38 hospitals, 30,291–31,155 samples)
• NDC 16714-0095-05 — Levalbuterol 0.63 mg/3 mL nebulizer solutionAI (26 hospitals, 30,291–31,155 samples)
• NDC 72603-0620-30 — Formoterol fumarate 20 mcg/2 mL nebulizer solutionAI (35 hospitals, 30,291–31,155 samples)
• NDC 09990-1155-00 — Dextrose 50% sugar solution syringe for IV useAI (24 hospitals, 30,291–31,155 samples)
• NDC 09990-2839-00 — Fentanyl and bupivacaine nerve block solutionAI (24 hospitals, 30,291–31,155 samples)
• NDC 09990-9632-00 — Sodium phosphate in saline infusion bagAI (24 hospitals, 30,291–31,155 samples)
• NDC 09990-9431-00 — Cardioplegia maintenance solution with potassium for perfusionAI (24 hospitals, 30,291–31,155 samples)